Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. HCA Healthcare, Inc.
  6. News
  7. Summary
    HCA   US40412C1018

HCA HEALTHCARE, INC.

(HCA)
  Report
Delayed Nyse  -  04:00 2022-06-24 pm EDT
182.33 USD   +2.76%
06/23HCA Healthcare, McKesson to Establish Oncology Research Joint Venture
MT
06/23McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical
AQ
06/23McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Mizuho Securities Adjusts HCA Healthcare's Price Target to $260 From $290, Reiterates Buy Rating

05/03/2022 | 09:13am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about HCA HEALTHCARE, INC.
06/23HCA Healthcare, McKesson to Establish Oncology Research Joint Venture
MT
06/23McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture t..
AQ
06/23McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture t..
BU
06/21RBC Cuts PT on HCA Healthcare to $256 From $267, Noting Industry-Wide Commentary on Slo..
MT
06/17Standard & Poor's 500 Enters Bear Market Territory as Fed Pivot to Price Stability Fuel..
MT
06/17HCA Healthcare Estimates Lowered by Oppenheimer; Firm Retains Positive Outlook
MT
06/17Oppenheimer Adjusts HCA Healthcare Price Target to $255 From $290, Maintains Outperform..
MT
06/17HCA Healthcare, Inc. has cancelled the acquisition of Five Utah Hospitals from Steward ..
CI
06/16Loop Capital Initiates HCA Healthcare with Buy Rating, $240 Price Target
MT
06/15HCA HEALTHCARE, INC. : Ex-dividend day for
FA
More news
Analyst Recommendations on HCA HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2022 60 670 M - -
Net income 2022 5 153 M - -
Net Debt 2022 35 097 M - -
P/E ratio 2022 10,6x
Yield 2022 1,22%
Capitalization 53 876 M 53 876 M -
EV / Sales 2022 1,47x
EV / Sales 2023 1,38x
Nbr of Employees 244 000
Free-Float 75,6%
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 182,33 $
Average target price 248,42 $
Spread / Average Target 36,2%
EPS Revisions
Managers and Directors
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Thomas Fearn Frist Chairman
P. Martin Paslick VP-Information Technology & Services
Michael S. Cuffe Vice President & Chief Clinical Officer
Sector and Competitors
1st jan.Capi. (M$)
HCA HEALTHCARE, INC.-29.03%53 876
CVS HEALTH CORPORATION-8.38%119 709
LABORATORY CORPORATION OF AMERICA HOLDINGS-22.80%21 623
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY21.44%18 188
QUEST DIAGNOSTICS-18.90%15 767
FRESENIUS MEDICAL CARE AG & CO. KGAA-17.59%13 872